Sign up for our eNewsletters
Get the latest news and updates

Industry News

SK bioscience
From left to right: John-Arne Røttingen, CEO, Wellcome; Priya Agrawal, VP Health Equity and Partnerships, MSD; Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI); Raman Rao, CEO, Hilleman Laboratories; Ikjung Kim, VP Head of Global Business Development, SK bioscience.
The collaboration, which includes Merck Sharp & Dohme and Hilleman Laboratories, will focus on improving process yield and storage to support scalable vaccine production.
Jan. 23, 2026
Shutterstock
Genetic research Cell therapy is a therapy in which viable cells are injected. cell therapy research
The agreement covers clinical and commercial manufacturing support for Atsena’s inherited retinal disease programs.
Jan. 23, 2026
Cellular Origins
Cellular Origins robotics
The robotic-operated cell processing system is designed to reduce manual intervention while maintaining existing biological workflows, according to the companies.
Jan. 22, 2026
Shutterstock
science glass tube and molecule
The collaboration supports early-stage AAV development for a rare inherited disorder linked to phosphate regulation.
Jan. 22, 2026

Learning Resources

dreamstime_xxl_249582173
dreamstime_xxl_249582173
Sponsored
Innovators are redefining bioreactor technology, cell and gene therapy manufacturing, pharmaceutical packaging, and small molecule APIs. Pharma Manufacturing’s 2025 Innovation...
Dec. 8, 2025
cover_gettyimages1320311776
cover_gettyimages1320311776
Sponsored
Faced with increasing quality, risk, and talent pressures, pharma manufacturers are embracing smart manufacturing and automation to overcome these challenges. Find out in this...
Nov. 20, 2025
dreamstime_m_45052120
dreamstime_m_45052120
Sponsored
Advancements in cleanroom technology are redefining pharmaceutical manufacturing with energy-efficient HVAC, sustainable materials, and intelligent airflow. However, much more...
Oct. 28, 2025
animal_health_brochure
Sponsored
Explore proven alternatives to fetal bovine serum (FBS). Discover how donor bovine serum and other options can reduce cost and supply risks while maintaining performance in bioproductio...
Oct. 21, 2025

Podcast

Editors' (re)View

editreview
The annual J.P. Morgan Healthcare Conference in San Francisco brought together executives who are positive about this year’s prospects for the sector.
Jan. 16, 2026
editreview
Large pharmaceutical companies have promised to invest more than $370 billion over the next five years in the U.S., driven by Trump’s threat of pharma-specific tariffs.
Dec. 19, 2025
editreview
The deal is a win for Britain’s beleaguered pharma sector and comes after President Trump threatened to impose 100% tariffs on branded drugs imported to the U.S.
Dec. 5, 2025
editreview
This week, the industry saw a flurry of pharma manufacturing investment announcements as companies continue to onshore production in the United States.
Nov. 21, 2025

Production

raleigh_skyline
Raleigh-Cary and Durham-Chapel Hill secured the first and third spots, respectively, as the nation’s most competitive markets for the production of therapeutic biologics.
Nov. 10, 2025
symphonxfinal
SymphonX, which runs all downstream unit operations in both fed-batch and continuous processes, will serve customers at Fujifilm’s Billingham manufacturing facility.
Nov. 6, 2025
elevatebiofinal
With $1.3 billion in funding, the company has established a cGMP manufacturing facility in Waltham, Massachusetts, with a second site under construction in Pittsburgh.
Nov. 5, 2025
motm_cgt_manufacturingfinal
Panelists at the 2025 Cell & Gene Meeting on the Mesa laid out the challenges and opportunities facing the industry as it looks to produce these therapies at scale.
Oct. 7, 2025

Development

shutterstock_radiopharmafinal
Manufacturers face growing pressure to align drug design, production strategy, logistics, and workforce planning to ensure reliable, at-scale delivery.
Jan. 6, 2026
hikmagroundbreaking
Report finds 40 states and Puerto Rico are offering sales and tax exemptions to lower costs for new biomanufacturing and research and development facilities.
Dec. 4, 2025
PlantForm
2171_plantform_104_high_res
Advances in glycosylation control, plant engineering, and rapid-expression systems are redefining what’s possible for plant-made drugs and vaccines.
Nov. 13, 2025
fdawhiteoakbuilding
The agency is reviewing clinical trials that involve sending U.S. patients’ living cells to China and other “hostile countries” for genetic engineering and return infusion.
Sept. 22, 2025

Information Technology

resilience2
Software platforms can seamlessly integrate with emerging technologies to unlock efficiencies, strengthen sustainability and enable proactive prevention of disruptions.
Sept. 10, 2025
2_1200xundefined
Sponsored
Pharmaceutical manufacturing operates in a high-stakes environment where regulatory compliance, product integrity, and operational uptime are non-negotiable. As the industry becomes...
March 5, 2025
cdmo_trends_brief_image_1540x800
Sponsored
Discover the latest contract manufacturing key trends for the life science industry, including compliance, digital transformation and more. Don't let your organization fall behind...
Feb. 24, 2025
key_to1
Sponsored
As the life sciences sector evolves with personalized medicine, biologics, and digitalization, manufacturers must innovate, invest in advanced tech, and adopt agile manufacturing...
Jan. 30, 2025

Compliance

fda_shutterstock
While the FDA was hit with staffing and budget cuts this year, the agency managed to increase its inspection and enforcement activities.
Dec. 29, 2025
trump
In exchange for discounts to list prices on select medicines, the companies will receive relief from potential pharmaceutical tariffs over a three-year period.
Dec. 22, 2025
fdawhiteoakbuilding
The agency cited “significant violations” of current Good Manufacturing Practice regulations for finished pharmaceuticals at Novo Nordisk’s Bloomington facility.
Dec. 18, 2025
sun_pharmafinal
The pharmaceutical company is investing in a greenfield project as it looks to resolve ongoing FDA compliance issues at three existing Indian facilities.
Dec. 3, 2025

Quality & Risk

shutterstock_2026final
Biomanufacturing scaling and supply chain resilience are top priorities for biopharma companies as they look to mitigate risks and capitalize on growth opportunities.
Jan. 5, 2026
shipcontainersheroimage
The industry requires local resilience and flexibility in a complex global landscape, according to separate reports from consulting firms Deloitte and West Monroe.
Dec. 11, 2025
aipicfinal
The adoption of artificial intelligence has evolved with investment shifting from monitoring to predictive intelligence, according to the 2025 LogiPharma AI Report.
Nov. 17, 2025
cytiva_biopharma
Cytiva’s 2025 Global Biopharma Index shows widening gaps across regions as talent shortages, regulatory strain, and uneven sustainability progress weigh on growth.
Oct. 27, 2025